Trial intelligence / Profile preview

Femoral Nerve Block vs Adductor Canal Nerve Block for ACL Reconstruction

NCT03033589Completed

Sponsor
Henry Ford Health
Start
May 2016
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in pain (2 arms), sponsored by Henry Ford Health. Primary endpoints: Visual Analog Scale at Day 3 and Narcotic Consumption at Day 3. Started May 2016; status: completed.

02

Drugs

bupivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT03033589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03033589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call